Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Gil

Showing results (1-10 of 303) with videos related to

Pageof 31
Sort By:
Revista Espanola De Geriatria Y Gerontologia|February 25, 2009
[To investigate it is possible]Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|October 11, 2016
[Diagnostic criteria. Benefits of early diagnosis]Pedro Gil Gregorio
Pharmacogenomics|October 16, 2008
Amodiaquine pharmacogeneticsJose Pedro Gil
Medicina Clinica|April 13, 2016
[Thoughts about anticoagulation in older patients]Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|April 10, 2018
[Clinical assessment and diagnostic tools]Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|April 10, 2018
Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|January 10, 2012
[The future of the Spanish Journal of Geriatrics and Gerontology forever attached to the Spanish Geriatrics and Gerontology Society]Francesc Formiga, Pedro Gil,
Expert Opinion on Drug Metabolism & Toxicology|September 9, 2011
The pharmacogenetics of antimalaria artemisinin combination therapyRita Piedade, José Pedro Gil
Frontiers in Pharmacology|November 18, 2021
<i>Plasmodium falciparum</i> Multidrug Resistance Proteins (<i>pf</i>MRPs)José Pedro Gil, Cláudia Fançony
Expert Review of Anti-Infective Therapy|March 30, 2017
pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapiesJ Pedro Gil, S Krishna
Pageof 31

Showing results (1-10 of 303) with videos related to

Sort By:
Pageof 31
Revista Espanola De Geriatria Y Gerontologia|February 25, 2009
[To investigate it is possible]Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|October 11, 2016
[Diagnostic criteria. Benefits of early diagnosis]Pedro Gil Gregorio
Pharmacogenomics|October 16, 2008
Amodiaquine pharmacogeneticsJose Pedro Gil
Medicina Clinica|April 13, 2016
[Thoughts about anticoagulation in older patients]Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|April 10, 2018
[Clinical assessment and diagnostic tools]Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|April 10, 2018
Pedro Gil Gregorio
Revista Espanola De Geriatria Y Gerontologia|January 10, 2012
[The future of the Spanish Journal of Geriatrics and Gerontology forever attached to the Spanish Geriatrics and Gerontology Society]Francesc Formiga, Pedro Gil,
Expert Opinion on Drug Metabolism & Toxicology|September 9, 2011
The pharmacogenetics of antimalaria artemisinin combination therapyRita Piedade, José Pedro Gil
Frontiers in Pharmacology|November 18, 2021
<i>Plasmodium falciparum</i> Multidrug Resistance Proteins (<i>pf</i>MRPs)José Pedro Gil, Cláudia Fançony
Expert Review of Anti-Infective Therapy|March 30, 2017
pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapiesJ Pedro Gil, S Krishna
Pageof 31